Infarct Volume Is a Pivotal Biomarker After Intra-Arterial Stroke Therapy

Abstract

Among patients with anterior circulation acute ischemic stroke who undergo intra-arterial therapy, final infarct volume is a critical determinant of 3-month functional outcome and appears suitable as a surrogate biomarker in proof-of-concept intra-arterial therapy trials.